Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dainippon To Buy Kyowa’s Chinese Unit For Production Facility

This article was originally published in PharmAsia News

Executive Summary

Japan's Dainippon Sumitomo Pharma plans to buy a Chinese subsidiary of Kyowa Hakko Kirin, also of Japan. The price of the acquisition was not revealed, but is estimated at about $15.7 million. The agreement would give Dainippon control of Kyowa Hakko Pharmaceuticals, which has a production plant capable of making about 100 million doses a year, but yet to be placed into service. The deal is believed to fit Dainippon's operating style because it now exports products from Japan to China. Dainippon expects to have the Kyowa plant in operation in 2010. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts